docetaxel anhydrous has been researched along with salinomycin in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (salinomycin) | Trials (salinomycin) | Recent Studies (post-2010) (salinomycin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 672 | 30 | 409 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | salinomycin (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, HS; Kim, JH; Ro, J; Yoo, HI; Yoon, S | 1 |
| Back, JB; Bernardo, MM; Chen, YQ; Dean, I; Dzinic, SH; Han, X; Heath, E; Irish, J; Jakupovic, B; Kaplun, A; Li, X; Mujagic, A; Sakr, W; Sheng, S; Van Buren, E | 1 |
| Bai, B; Cao, Y; Cui, D; Gao, J; Li, L; Li, Y; Nie, Z; Yang, L; Ye, L; Zhu, L | 1 |
| Gao, J; Liu, J; Lu, Y; Shen, X; Xie, F; Yin, C | 1 |
| Li, R; Liu, B; Liu, F; Liu, Q; Meng, F; Wang, L; Wang, Q; Wei, J; Xie, C; Yen, YT; Yu, L | 1 |
5 other study(ies) available for docetaxel anhydrous and salinomycin
| Article | Year |
|---|---|
Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest.
Topics: Antimitotic Agents; Apoptosis; Cell Line, Tumor; Colchicine; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Docetaxel; Drug Resistance, Neoplasm; G2 Phase Cell Cycle Checkpoints; Humans; Paclitaxel; Pyrans; Taxoids; Vinblastine | 2012 |
Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Benzamides; Cell Adhesion; Cell Culture Techniques; Cell Dedifferentiation; Cell Line, Tumor; Cell Plasticity; Cell Self Renewal; Cellular Senescence; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Profiling; Heterografts; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; Phenotype; Prostatic Neoplasms; Pyrans; Pyridines; Serpins; Suspensions; Taxoids; Tumor Microenvironment | 2015 |
Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Delayed-Action Preparations; Docetaxel; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyethylene Glycols; Polyglactin 910; Pyrans; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays | 2017 |
Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Delivery Systems; Drug Liberation; Female; Humans; Liposomes; Male; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Neoplastic Stem Cells; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrans; Rats, Sprague-Dawley; Tissue Distribution; Vitamin E; Xenograft Model Antitumor Assays | 2019 |
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Gelatinases; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Neoplastic Stem Cells; Polyesters; Polyethylene Glycols; Pyrans; Uterine Cervical Neoplasms | 2021 |